Manufacturer copay assistance · Injectafer (J1439) · Daiichi Sankyo
$50/dose · Maximum benefit Up to $2,000 per calendar year · Covers Injectafer drug cost only — does not cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Injectafer — check the full fund board.
Run a benefits estimate for Injectafer — the program's cap applies against the patient share CareCost calculates.
Yes — Injectafer Savings Program from Daiichi Sankyo. Patient pays $50 per dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $50 per dose Maximum benefit: Up to $2,000 per calendar year. Covers Injectafer drug cost only — does not cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.